Mekong Capital's Mekong Enterprise Fund IV has acquired a stake in TNH Hospital Group, enhancing its capabilities to provide high-quality healthcare services in Vietnam.

Target Information

Mekong Capital, a prominent investment firm, has announced that its Mekong Enterprise Fund IV (MEF IV) has acquired a stake in TNH Hospital Group Joint Stock Company. Established in 2012, TNH has emerged as a leading private hospital network in Vietnam, recognized for delivering high-quality healthcare services at affordable prices. Initially known as Thai Nguyen International Hospital Joint Stock Company, TNH officially rebranded in July 2024. The hospital's senior leadership includes Dr. Hoang Tuyen, Chairman of the Board of Directors, and People’s Doctor – Senior Doctor Le Xuan Tan, who serves as Vice Chairman and General Director.

Headquartered in Thai Nguyen City, an economic and medical hub for Vietnam's northern midlands and mountainous regions, TNH has experienced significant growth. In just over a decade, it has developed a modern hospital system encompassing three facilities with a combined capacity of 700 licensed beds and a skilled workforce exceeding 800 staff members, including over 600 healthcare professionals. Its key establishments include the Thai Nguyen International Hospital, which offers premium services, the Yen Binh Thai Nguyen General Hospital catering to industrial parks in Pho Yen City, and the TNH Viet Yen Hospital in Bac Giang.

Industry Overview in Vietnam

The healthcare industry in Vietnam has been witnessing rapid growth, driven by increasing demand for quality healthcare services alongside the country's evolving economic landscape. The government has prioritized health system reforms, a

View Source

Similar Deals

Boston Scientific Nalu Medical

2026

Strategic Partnership Medical Devices & Implants United States of America
Barça Innovation Hub Omniscope

2025

Strategic Partnership Biotechnology & Medical Research (NEC) Spain
Otsuka Pharmaceutical Co., Ltd. 4D Molecular Therapeutics

2025

Strategic Partnership Bio Therapeutic Drugs Japan
Cressey & Company LP Paradigm Health

2025

Strategic Partnership Residential & Long-Term Care United States of America
Roche Oxford BioTherapeutics

2025

Strategic Partnership Bio Therapeutic Drugs United Kingdom
Welsh, Carson, Anderson & Stowe Constitution Surgery Alliance

2025

Strategic Partnership Healthcare Facilities & Services (NEC) United States of America

Mekong Capital

invested in

TNH Hospital Group Joint Stock Company

in 2025

in a Strategic Partnership deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert